An ACCP International Symposium

September 13, 2019   
Governor's Hall, St. Thomas’ Hospital
London, United Kingdom

Goal

To educate and engage pharmacists in applying scientific and clinical evidence to real-world patient cases on the management of antimicrobial resistance to optimize patient care and outcomes.

Target Audience

The target audience is pharmacists and pharmacy trainees providing care to patients with infectious diseases. 

Symposium Objectives

At the conclusion of the symposium, the participant should be able to:

1. Discuss the evolution and current understanding of the mechanisms of antimicrobial resistance 
2. Evaluate effectiveness of antimicrobial therapy for multi-drug resistant gram-positive and gram-negative pathogens
3. Recommend management strategies for multi-drug resistant gram-positive and gram-negative infections
4. Devise a monitoring plan to assess for efficacy and safety of antimicrobial therapy
5. Apply contemporary clinical evidence to optimize health and patient outcomes

Agenda

Session Learning Objectives

Antimicrobial Resistance: Threats and Pathogenesis

At the conclusion of the session, the participant should be able to:

1. Discuss risk factors for development of resistance within Staphylococcus aureus, Enterococci, and Streptococcus pneumoniae
2. Identify significant mechanisms of resistance within Staphylococcus aureus, Enterococci, and Streptococcus pneumoniae and subsequent clinical implications
3. Discuss risk factors for development of resistance within gram-negative bacteria
4. Identify significant mechanisms of resistance within gram-negative bacteria with subsequent clinical implications

Multi-Drug Resistant Gram-Positive Infections: Evidence-Based Management and Outcomes

At the conclusion of the session, the participant should be able to:

1. Identify most current data regarding treatment outcomes of multi-drug resistant gram-positive infections
2. Compare and contrast pharmacotherapy options using head to head data when available
3. Discuss outcomes regarding monotherapy versus dual therapy of invasive Staphylococcus aureus and Enterococcal infections

Multi-Drug Resistant Gram-Negative Infections: Evidence-Based Management and Outcomes

At the conclusion of the session, the participant should be able to:

1. Identify most current data regarding treatment outcomes of multi-drug resistant gram-negative infections
2. Compare and contrast pharmacotherapy options using head to head data when available
3. Discuss outcomes regarding monotherapy versus dual therapy of gram-negative bloodstream infections

Patient Cases: Applying the Evidence

At the conclusion of the session, the participant should be able to:

1. Formulate pharmacotherapy regimens for complicated cases involving multi-drug resistant gram-positive infections
2. Develop alternative pharmacotherapy treatment plans for multi-drug resistant gram-positive infections
3. Formulate pharmacotherapy regimens for complicated cases involving multi-drug resistant gram-negative infections
4. Develop alternative pharmacotherapy treatment plans for multi-drug resistant gram-negative infections

Symposium Moderator

Wafa Y. Dahdal, Pharm.D.
Director of International Programs & 
Associate Director of Professional Development
American College of Clinical Pharmacy

Program Faculty

Christopher M. Bland, Pharm.D., FCCP, FIDSA, BCPS
Clinical Associate Professor
University of Georgia College of Pharmacy
Clinical Pharmacy Specialist
St. Joseph’s/Candler Health System

 

Faculty Disclosures

Dr. Bland: Consultancy/advisory board (Paratek Pharmaceuticals, bioMérieux); Speaker’s bureau (Merck & Co., Tetraphase Pharmaceuticals); Grants (ALK-Abelló)

Dr. Dahdal has no relevant affiliations or financial relationships with commercial interest to disclose.

Continuing Pharmacy Education Credit

The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education (CPE).

 

ACCP designates this activity for 6.0 CPE hours. Partial credit is not available. 

Type of Activity: Application-based
Universal Activity Number: 0217-0000-19-171-L01-P
Expiration Date: October 25, 2019         

To earn CPE credit for this activity, the participant must attend all 6.0 contact hours of programming, complete the associated program evaluation, and claim credit at www.accp.com/ce by October 25, 2019.

To obtain a statement of credit for this activity, international participants must update their ACCP profile at www.accp.com/myaccount/licensure.aspx by checking the box for “I am an international pharmacist or I am not licensed to practice in the United States, and do not have an NABP e-Profile ID.” Participants with an NABP e-Profile ID on file with ACCP will obtain their statement of credit from www.mycpemonitor.net.

Certificates of Attendance

Certificates of attendance will be granted to participants attending the entire symposium. Certificates will be issued electronically within 4 weeks of symposium completion.

Registration and Fees

Pharmacists

Registration and payment received:	Fee*
On or before August 9, 2019	$200
Before September 13, 2019	$225
On September 13, 2019**	$250

*Fees are in U.S. Dollars
**Only credit card payments will be accepted for onsite registrations.

Registration fee includes program book, opportunity to earn 6.0 application-based, continuing pharmacy education (CPE) credits, a certificate of attendance, lunch, and two tea breaks.

Students

Student registration is available here.

Cancellation Policy

• Registration cancellations for the ACCP International Symposium must be notified in writing, by email to ACCP at [email protected].
• Cancellations received on or before August 9, 2019 will be refunded the registration fee, less an administration charge of $50. Refunds will be processed 4 weeks after the event completion date.
• Cancellations received after August 9, 2019 and no shows are not eligible for a refund.

Commercial Support

No commercial support has been received for this activity.

Symposium Venue

The 2019 ACCP International Symposium will be held at Governor's Hall, St. Thomas' Hospital.

Governor’s Hall
1^st Floor, South Wing
St. Thomas’ Hospital
Westminster Bridge Rd
Lambeth, London SE1 7EH, UK

Map of St. Thomas’ Hospital and directions to Governor's Hall is available here.

Information on travel to St. Thomas’ Hospital is available here. 

Accommodations

Information on accommodations in London can be found here.

Visa Invitation Letters

Invitation letters will be issued to attendees who have paid their registration fee in full. After completing the registration, please submit an invitation letter request to [email protected].

Enquiries

Direct any enquiries about the 2019 ACCP International Symposium to [email protected].